speb/financial-data huggingface dataset:
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 652800000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1660500000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1093300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 662800000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Net Interest Income: -262400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: 93000000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1253400000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -156700000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -156700000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -262400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 93000000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -636700000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1515700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1515700000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -572200000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 8295600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 8295600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 1640700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1640700000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 129100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 129100000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 2471800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 2471800000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2219400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1064600000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Normalized Income: 1056146918.27
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 643110707.23
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 2819100000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Operating Income: 1655200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1060300000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Operating Revenue: 17173800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7186700000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 76004409.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 76004409.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 7200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7200000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 62100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 62100000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 13800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 13800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 5600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5600000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 223200000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 46800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 46800000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 208200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -210000000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 505500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -514600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Payable: 549800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 549800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Properties: 220900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 220900000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 52600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 52600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2301600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2301600000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Other Special Charges: -1100000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Payables: 6129900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Payables: 6129900000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 163500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 163500000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 3545400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 3545400000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Pretax Income: 1711700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1012400000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 17600000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -246700000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -3945900000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -574600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 526000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 526000000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 12968400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5391200000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 142800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 42700000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 21200000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 21200000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -4295800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1039700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1039700000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 5917700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 5917700000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 152500000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 2692500000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2400000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 705400000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 939000000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Share Issued: 76004409.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 76004409.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Special Income Charges: 1100000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 1100000.00
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 13600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 8301200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8301200000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 8295600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 8295600000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 5346918.27
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 5110707.23
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Tax Provision: 618400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 349600000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.36
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.35
KOLTEPATIL.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -291400000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Assets: 53044800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 53044800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 8343900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8343900000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Debt: 11389800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 11389800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8373200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8373200000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Total Expenses: 15518600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 6126400000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 44671600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 44671600000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 7565900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7565900000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 383900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 383900000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 39400000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 146100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 146100000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 14800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 14800000.00
KOLTEPATIL.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 14800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 14800000.00
KOLTEPATIL.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1191200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1191200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 586600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 823600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 76877828.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -2.21
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 538700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 42200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 42200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 76877828.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.21
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — EBIT: -154600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — EBITDA: -112400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 284900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 67400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 67400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -1100000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -168800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -168800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -67400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -67400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -112400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -169900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Operating Income: -301700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 823600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 144500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 306200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -222000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 538700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 42200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -53200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
KOLTEPATIL.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1125300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 789700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1386600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6005100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 727100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1084000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 88389831.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -1.18
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 299800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 886800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1149600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10146100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 886800000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 12222900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1011400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 56612000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 84300000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 10196100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 10280400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 51870600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 168800000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 42200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 42200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 88389831.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.18
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — EBIT: -107600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — EBITDA: -65400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1581000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 375200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 32700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 32700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 42793600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 22443700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 167400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1084000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 215500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 24700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 240200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 130500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: -33600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 7100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 9071200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -111400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -111400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -32700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -32700000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1581000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 12218400000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1681200000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -65400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -104300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Operating Income: -414500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1386600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 88680094.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2945200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 34093000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 11336100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2566500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 230900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 474000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1581000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 8996500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Payables: 6018600000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -140300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1011400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 42200000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 88680094.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 12222900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 12218400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -28900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 64441900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 12247600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 10520600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 12189300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1801100000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 52252600000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7829900000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 382000000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 13500000.00
KOLTEPATIL.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 4741400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 722300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2653300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 88235294.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.51
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1889900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 39700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 39700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 88235294.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.51
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — EBIT: 207400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — EBITDA: 247100000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 763400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 105400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 105400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 2700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 42300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 42300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -105400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -105400000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 247100000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 45000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Operating Income: 41100000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2653300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 164500000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 425300000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 102000000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1889900000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 39700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 59700000.00
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
KOLTEPATIL.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2612200000.00
KOMN.SW balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 13000.00
KOMN.SW cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
KOMN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 299632000.00
KOMN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 602306000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 35017000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 181549000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -93544000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 348591000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2124000.00
KOMN.SW income_statement (annual, 2022-12-31) — Amortization: 4753000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 4753000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 16686000.00
KOMN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 4273799.00
KOMN.SW income_statement (annual, 2022-12-31) — Basic EPS: 12.11
KOMN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 50671000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 194671000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -13081000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 513000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 82735000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 82747000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -17303000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -24776000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 19706000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Change In Payable: 1398000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -35607000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -39710000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: 34809000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 513000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -17303000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 416589000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 4782000.00
KOMN.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 230661000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 522882000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Current Debt: 12382000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 12382000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 181461000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 5207000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Deferred Tax: 13067000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Depreciation: 12454000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 17207000.00
KOMN.SW income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 17207000.00
KOMN.SW income_statement (annual, 2022-12-31) — Depreciation Income Statement: 12454000.00
KOMN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 4292879.00
KOMN.SW income_statement (annual, 2022-12-31) — Diluted EPS: 12.06
KOMN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — EBIT: 72013000.00
KOMN.SW income_statement (annual, 2022-12-31) — EBITDA: 89220000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -2745000.00
KOMN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 82735000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: 17187000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 53770000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 25929000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 62000.00
KOMN.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 12167000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 19760000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 183673000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 312240000.00
KOMN.SW income_statement (annual, 2022-12-31) — Gross Profit: 371645000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -6484000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Interest Received Cfo: 1341000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -19306000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Inventory: 204743000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 604848000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: -21388000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 50000000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Land And Improvements: 31640000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 175877000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 175877000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 45000000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -15510000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 64698000.00
KOMN.SW income_statement (annual, 2022-12-31) — Minority Interests: 0.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -8721000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Net Debt: 105524000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 3893000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 51773000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 51773000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 51773000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -4245000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -3106000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 34490000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 29490000.00
KOMN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -3106000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 218696000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -8422000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 5000000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 396829000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 20612000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 7462000.00
KOMN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 89501000.00
KOMN.SW income_statement (annual, 2022-12-31) — Normalized Income: 51997238.00
KOMN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 39010000.00
KOMN.SW income_statement (annual, 2022-12-31) — Operating Income: 72013000.00
KOMN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 602306000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 5128682.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 19760000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: 3106000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2117000.00
KOMN.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 25185000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 23977000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Properties: 16449000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 30634000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 12000.00
KOMN.SW income_statement (annual, 2022-12-31) — Other Special Charges: 281000.00
KOMN.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Payables: 69658000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6565000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 6523000.00
KOMN.SW income_statement (annual, 2022-12-31) — Pretax Income: 64840000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
KOMN.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: -9280000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -4245000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -8836000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 123138000.00
KOMN.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 230661000.00
KOMN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 17207000.00
KOMN.SW income_statement (annual, 2022-12-31) — Rent And Landing Fees: 3943000.00
KOMN.SW income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 3943000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -15510000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
KOMN.SW income_statement (annual, 2022-12-31) — Research And Development: 9517000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 68500000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Sale Of Business: 559000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 0.00
KOMN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 414000.00
KOMN.SW income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 23560000.00
KOMN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 35727000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 5133333.00
KOMN.SW cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 5000000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
KOMN.SW income_statement (annual, 2022-12-31) — Special Income Charges: -281000.00
KOMN.SW cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1959000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 416589000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 396829000.00
KOMN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -56762.00
KOMN.SW income_statement (annual, 2022-12-31) — Tax Provision: 13067000.00
KOMN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.20
KOMN.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -7097000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 783506000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 592466000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 188259000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 416589000.00
KOMN.SW income_statement (annual, 2022-12-31) — Total Expenses: 530293000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 366917000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 260624000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 185456000.00
KOMN.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 71732000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 10664000.00
KOMN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: -281000.00
KOMN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -281000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 4651.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 1015000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Work In Process: 47141000.00
KOMN.SW balance_sheet (annual, 2022-12-31) — Working Capital: 341421000.00
KOMN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 399924000.00
KOMN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 759448000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 27486000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 138104000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -102734000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 334475000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1263000.00
KOMN.SW income_statement (annual, 2023-12-31) — Amortization: 6460000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 6460000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
KOMN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 5124960.00
KOMN.SW income_statement (annual, 2023-12-31) — Basic EPS: 8.55
KOMN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 82735000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 199692000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -28535000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 513000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 76237000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 76258000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -28232000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 2077000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -22741000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Change In Payable: -9834000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 34252000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: 4230000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: -2073000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 513000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -28232000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 390596000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Common Stock Payments: -4738000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 5002000.00
KOMN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 286528000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 448028000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Current Debt: 4013000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4013000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 144278000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 5364000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Deferred Tax: 17088000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Depreciation: 13718000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 20178000.00
KOMN.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 20178000.00
KOMN.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 13718000.00
KOMN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 5139972.00
KOMN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 8.53
KOMN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — EBIT: 72996000.00
KOMN.SW income_statement (annual, 2023-12-31) — EBITDA: 93174000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -4425000.00
KOMN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 76237000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -53761000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 49882000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 33531000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -11754000.00
KOMN.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 21945000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 19300000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 139367000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 325653000.00
KOMN.SW income_statement (annual, 2023-12-31) — Gross Profit: 472920000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -11275000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Interest Received Cfo: 1180000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -20643000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Inventory: 193592000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 559781000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -10378000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 0.00
KOMN.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Land And Improvements: 31495000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 165172000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 165172000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
KOMN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -12079000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 71713000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
KOMN.SW income_statement (annual, 2023-12-31) — Minority Interests: 0.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -12585000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -4738000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Net Debt: 92948000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 6698000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 43836000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 43836000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 43836000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -6216000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Interest Income: -5186000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -20791000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -12079000.00
KOMN.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -5186000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 222919000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 8423000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -8712000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 371296000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 17190000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 6625000.00
KOMN.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 93362000.00
KOMN.SW income_statement (annual, 2023-12-31) — Normalized Income: 43971360.00
KOMN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 62066000.00
KOMN.SW income_statement (annual, 2023-12-31) — Operating Income: 72996000.00
KOMN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 759448000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 5117537.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 19300000.00
KOMN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: 5186000.00
KOMN.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2246000.00
KOMN.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 35008000.00